eFFECTOR Therapeutics, Inc. (EFTR)
NASDAQ: EFTR · IEX Real-Time Price · USD
1.910
+0.130 (7.30%)
Apr 23, 2024, 1:07 PM EDT - Market open

eFFECTOR Therapeutics Statistics

Total Valuation

EFTR has a market cap or net worth of $7.04 million. The enterprise value is $8.74 million.

Market Cap 7.04M
Enterprise Value 8.74M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date May 7, 2024
Ex-Dividend Date n/a

Share Statistics

EFTR has 3.69 million shares outstanding. The number of shares has increased by 32.77% in one year.

Shares Outstanding 3.69M
Shares Change (YoY) +32.77%
Shares Change (QoQ) -11.49%
Owned by Insiders (%) 3.63%
Owned by Institutions (%) 17.57%
Float 3.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.77

Current Ratio 0.77
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.27

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -160.00%
Return on Capital (ROIC) -229.45%
Revenue Per Employee n/a
Profits Per Employee -$2.56M
Employee Count 14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.94% in the last 52 weeks. The beta is 0.52, so EFTR's price volatility has been lower than the market average.

Beta (1Y) 0.52
52-Week Price Change -81.94%
50-Day Moving Average 10.10
200-Day Moving Average 13.42
Relative Strength Index (RSI) 27.03
Average Volume (30 Days) 384,800

Short Selling Information

The latest short interest is 345,200, so 9.36% of the outstanding shares have been sold short.

Short Interest 345,200
Short Previous Month 318,066
Short % of Shares Out 9.36%
Short % of Float 10.23%
Short Ratio (days to cover) 1.54

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -33.84M
Pretax Income -35.81M
Net Income -35.81M
EBITDA -32.78M
EBIT -32.89M
Earnings Per Share (EPS) -$16.37
Full Income Statement

Balance Sheet

The company has $18.37 million in cash and $20.55 million in debt, giving a net cash position of -$2.18 million or -$0.59 per share.

Cash & Cash Equivalents 18.37M
Total Debt 20.55M
Net Cash -2.18M
Net Cash Per Share -$0.59
Equity / Book Value -5.80M
Book Value Per Share -1.57
Working Capital -5.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.55 million and capital expenditures -$97,000, giving a free cash flow of -$29.65 million.

Operating Cash Flow -29.55M
Capital Expenditures -97,000
Free Cash Flow -29.65M
FCF Per Share -$13.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

EFTR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -32.77%
Shareholder Yield -32.77%
Earnings Yield -545.62%
FCF Yield -451.70%

Analyst Forecast

The average price target for EFTR is $112.17, which is 5,772.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target $112.17
Price Target Difference 5,772.78%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 12, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date Jan 12, 2024
Split Type Reverse
Split Ratio 1:25

Scores

Altman Z-Score n/a
Piotroski F-Score 1